Total Payments
$280,697
2024 Payments
$74,394
Companies
23
Transactions
527
Medicare Patients
12,981
Medicare Billing
$995,922
Payment Breakdown by Category
Other$247,537 (88.2%)
Travel$28,054 (10.0%)
Food & Beverage$4,758 (1.7%)
Gifts$342.00 (0.1%)
Education$5.26 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $247,538 | 297 | 88.2% |
| Travel and Lodging | $28,054 | 52 | 10.0% |
| Food and Beverage | $4,758 | 176 | 1.7% |
| Gift | $342.00 | 1 | 0.1% |
| Education | $5.26 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $274,831 | 417 | $0 (2024) |
| Tandem Diabetes Care, Inc. | $3,800 | 11 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $497.40 | 54 | $0 (2021) |
| Tosoh Bioscience, Inc. | $342.00 | 1 | $0 (2018) |
| Medtronic, Inc. | $223.50 | 4 | $0 (2022) |
| Abbott Laboratories | $196.54 | 9 | $0 (2023) |
| Medtronic MiniMed, Inc. | $149.50 | 4 | $0 (2018) |
| Amgen Inc. | $140.88 | 7 | $0 (2024) |
| Insulet Corporation | $137.31 | 3 | $0 (2022) |
| CeQur Corporation | $72.09 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $74,394 | 120 | Lilly USA, LLC ($74,167) |
| 2023 | $90,821 | 149 | Lilly USA, LLC ($90,659) |
| 2022 | $69,878 | 107 | Lilly USA, LLC ($69,607) |
| 2021 | $25,255 | 49 | Lilly USA, LLC ($25,025) |
| 2020 | $17,927 | 47 | Lilly USA, LLC ($15,373) |
| 2019 | $950.26 | 39 | Tandem Diabetes Care, Inc. ($650.00) |
| 2018 | $1,261 | 9 | Tandem Diabetes Care, Inc. ($800.00) |
| 2017 | $211.18 | 7 | Medtronic MiniMed, Inc. ($119.58) |
All Payment Transactions
527 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/10/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $700.00 | General |
| Category: Diabetes | ||||||
| 10/28/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $700.00 | General |
| Category: Diabetes | ||||||
| 10/21/2024 | CeQur Corporation | CeQur Simplicity (Device) | Food and Beverage | Cash or cash equivalent | $51.14 | General |
| Category: Diabetes | ||||||
| 09/27/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Travel and Lodging | Cash or cash equivalent | $85.76 | General |
| Category: Diabetes | ||||||
| 09/25/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,400.00 | General |
| Category: Diabetes | ||||||
| 09/25/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $875.00 | General |
| Category: Diabetes | ||||||
| 09/23/2024 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $16.89 | General |
| 09/12/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $27.75 | General |
| Category: Inflammation/Rare Disease | ||||||
| 08/19/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $700.00 | General |
| Category: Diabetes | ||||||
| 07/19/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $700.00 | General |
| Category: Diabetes | ||||||
| 06/17/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $700.00 | General |
| Category: Diabetes | ||||||
| 06/04/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $22.15 | General |
| Category: Endocrinology | ||||||
| 05/23/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $700.00 | General |
| Category: Diabetes | ||||||
| 05/14/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $700.00 | General |
| Category: Diabetes | ||||||
| 05/14/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $24.05 | General |
| Category: Diabetes | ||||||
| 05/13/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Travel and Lodging | Cash or cash equivalent | $69.68 | General |
| Category: Diabetes | ||||||
| 05/08/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,400.00 | General |
| Category: Diabetes | ||||||
| 05/08/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $875.00 | General |
| Category: Diabetes | ||||||
| 05/06/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $700.00 | General |
| Category: Diabetes | ||||||
| 05/03/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $700.00 | General |
| Category: Diabetes | ||||||
| 05/02/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,400.00 | General |
| Category: Diabetes | ||||||
| 05/02/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $875.00 | General |
| Category: Diabetes | ||||||
| 04/29/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $633.15 | General |
| 04/29/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $23.73 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 33 | 3,819 | 9,410 | $622,547 | $249,152 |
| 2022 | 27 | 3,580 | 9,998 | $659,211 | $255,887 |
| 2021 | 17 | 2,874 | 9,486 | $680,830 | $269,551 |
| 2020 | 17 | 2,708 | 8,419 | $630,830 | $221,333 |
Total Patients
12,981
Total Services
37,313
Medicare Billing
$995,922
Procedure Codes
94
All Medicare Procedures & Services
94 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 50 | 4,681 | $117,025 | $86,138 | 73.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 587 | 862 | $155,160 | $77,105 | 49.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 139 | 139 | $57,268 | $15,779 | 27.6% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2023 | 121 | 124 | $37,076 | $9,996 | 27.0% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 329 | 438 | $31,536 | $7,193 | 22.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 37 | 37 | $18,574 | $5,802 | 31.2% |
| 82306 | Vitamin d-3 level | Office | 2023 | 153 | 178 | $21,716 | $5,164 | 23.8% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 113 | 188 | $11,656 | $4,896 | 42.0% |
| 83970 | Parathormone (parathyroid hormone) level | Office | 2023 | 80 | 107 | $17,441 | $4,328 | 24.8% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 264 | 442 | $22,100 | $4,208 | 19.0% |
| 10005 | Fine needle aspiration biopsy using ultrasound guidance, first growth | Office | 2023 | 39 | 40 | $14,000 | $4,080 | 29.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 27 | 29 | $8,816 | $3,875 | 44.0% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 317 | 407 | $20,350 | $3,589 | 17.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 297 | 339 | $3,729 | $2,848 | 76.4% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 71 | 71 | $27,406 | $2,577 | 9.4% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 129 | 136 | $8,840 | $1,784 | 20.2% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 145 | 152 | $7,144 | $1,573 | 22.0% |
| 84481 | Thyroid hormone, t3 measurement, free | Office | 2023 | 69 | 89 | $4,450 | $1,477 | 33.2% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 139 | 162 | $6,804 | $1,343 | 19.7% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 180 | 195 | $3,315 | $990.60 | 29.9% |
| 84403 | Testosterone (hormone) level, total | Office | 2023 | 26 | 29 | $2,175 | $733.41 | 33.7% |
| 82310 | Calcium level, total | Office | 2023 | 96 | 121 | $3,146 | $612.26 | 19.5% |
| 84146 | Prolactin (milk producing hormone) level | Office | 2023 | 19 | 23 | $3,749 | $436.77 | 11.7% |
| 82947 | Blood glucose (sugar) level | Office | 2023 | 103 | 109 | $4,360 | $419.65 | 9.6% |
| 82565 | Blood creatinine level | Office | 2023 | 73 | 79 | $1,580 | $396.58 | 25.1% |
About Dr. Lauren Bernstein, M.D
Dr. Lauren Bernstein, M.D is a Endocrinology, Diabetes & Metabolism healthcare provider based in Asheville, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1730241597.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lauren Bernstein, M.D has received a total of $280,697 in payments from pharmaceutical and medical device companies, with $74,394 received in 2024. These payments were reported across 527 transactions from 23 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($247,538).
As a Medicare-enrolled provider, Bernstein has provided services to 12,981 Medicare beneficiaries, totaling 37,313 services with total Medicare billing of $995,922. Data is available for 4 years (2020–2023), covering 94 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Asheville, NC
- Active Since 12/15/2006
- Last Updated 06/26/2025
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1730241597
Products in Payments
- MOUNJARO (Drug) $199,040
- TRULICITY (Drug) $48,627
- t:slim X2 insulin pump (Device) $2,350
- t-slim insulin pump (Device) $1,450
- INVOKANA (Drug) $348.93
- HEMOLYSIS/WASH SOL (2000 mL) (Medical Supply) $342.00
- XARELTO (Drug) $148.47
- Omnipod (Device) $137.31
- MINIMED 770G (Device) $136.69
- Minimed 630G (Device) $132.15
- InPen (Device) $86.81
- FREESTYLE LIBRE 3 (Device) $84.91
- TEPEZZA (Biological) $74.03
- CeQur Simplicity (Device) $72.09
- EVENITY (Biological) $50.46
- FreeStyle Libre 2 (Device) $43.56
- GVOKE HYPOPEN (Drug) $37.55
- Senza (Device) $36.54
- Eversense (Device) $29.00
- OneTouch (Device) $28.80
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Asheville
Richard Dodd, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $924,614
Endocrinology, Diabetes & Metabolism $924,614
Dr. Victor Marlar, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $815,366
Endocrinology, Diabetes & Metabolism $815,366
Dr. Wendy Lane, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $733,259
Endocrinology, Diabetes & Metabolism $733,259
David Hester, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $23,730
Endocrinology, Diabetes & Metabolism $23,730
Stephen Weinrib, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $16,625
Endocrinology, Diabetes & Metabolism $16,625
Dr. Brian Cumbie, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $9,320
Endocrinology, Diabetes & Metabolism $9,320